Position in GEHC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,561,364,385
-$468,349,910 QoQ
Shares Held
35,984,327
-2.6% QoQ
Ownership
7.91%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GEHC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026BlackRock, Inc. holds $66,751,105,265 across 112 Medical Devices names. GEHC ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
145,687,458 | $14,957,731,302 | |
| 2 | MDT |
Medtronic plc
|
113,182,567 | $9,807,269,421 | |
| 3 | SYK |
Stryker Corp
|
27,602,049 | $9,069,757,269 | |
| 4 | BSX |
Boston Scientific Corp
|
131,822,037 | $8,271,832,814 | |
| 5 | EW |
Edwards Lifesciences Corp
|
52,590,933 | $4,211,481,905 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
This page
|
35,984,327 | $2,561,364,385 | |
| 7 | DXCM |
Dexcom Inc
|
38,964,371 | $2,446,962,491 | |
| 8 | STE |
STERIS plc
|
9,026,621 | $1,996,056,695 |
All Filings in GEHC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,561,364,385 | 35,984,327 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,029,714,295 | 36,938,726 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,744,792,189 | 36,548,498 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,655,481,265 | 35,850,969 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,085,715,524 | 38,232,134 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,949,498,649 | 37,727,023 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,402,872,417 | 36,258,630 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||